Advertisement

Netherlands Heart Journal

, Volume 19, Issue 10, pp 403–404 | Cite as

Treatment of atrial fibrillation in the elderly: time for a change?

  • L. R. C. DekkerEmail author
Editorial

Atrial fibrillation (AF) is the most common arrhythmia. The prevalence of AF is highly age dependent as the median age of AF patients is 75 years and at least 70% of AF patients are between 65 and 85 years old [1, 2]. With increasing life expectancy, AF prevalence will increase 2.5 times during the next 40 years and constitute an even more important health concern [1].

Symptoms may change as AF progresses from paroxysmal to permanent, especially in the elderly. Palpitations are more common among patients <65 years compared with patients aged 65–80 years (61% and 46%, respectively). However, other symptoms, such as dyspnoea and fatigue, are more prevailing in the elderly resulting in overall presence of symptoms in 75% among patients <65 years and 67% among patients between 65 and 80 years (Euro Heart Survey on AF, personal communications by HJGM Crijns). Care of AF patients poses a very high economic burden on society. The annual costs of the average AF patient are over 3000 euro (3600...

Notes

Acknowledgements

This study is financially supported by St Jude Medical.

The unpublished data from the Euro Heart Survey on AF provided by Prof. Dr. HJGM Crijns are gratefully accepted.

References

  1. 1.
    Go AS, Hylek EM, Phillips BA. Atrial fibrillation in adults. ATRIA study. JAMA. 2001;285:2370–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patient with atrial fibrillation. JACC. 2006;48:e149–246.Google Scholar
  3. 3.
    AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.CrossRefGoogle Scholar
  4. 4.
    Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med. 2000;342:913–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–429.PubMedCrossRefGoogle Scholar
  6. 6.
    Bunch TJ, Weiss JP, Crandall BG, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. PACE. 2010;33:146–55.PubMedGoogle Scholar
  7. 7.
    Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Media / Bohn Stafleu van Loghum 2011

Authors and Affiliations

  1. 1.Department of CardiologyCatharina HospitalEindhoventhe Netherlands

Personalised recommendations